Effect of cytomegalovirus infection on 1-year mortality rates among recipients of allogeneic bone marrow transplants

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
A HumarT Mazzulli

Abstract

The effect of cytomegalovirus (CMV) infection on 1-year mortality rates among allogeneic bone marrow transplant recipients who are receiving a standard protocol as prophylaxis for CMV infection is unclear. We determined the risk factors for death within 1 year among 103 bone marrow transplant recipients by performing a multivariate analysis. The results of donor and recipient CMV serologies did not predict 1-year mortality, although there was a trend towards higher mortality among CMV-seropositive recipients who received marrow from seronegative donors (P = .077). Multivariate analysis revealed that the factors independently associated with 1-year mortality were the development of CMV antigenemia (relative risk [RR] = 2.74; confidence interval [CI] = 1.28-5.86), bone marrow transplantation (BMT) from unrelated donors (RR = 3.20; CI = 1.30-7.92), and severe acute graft-versus-host disease (RR = 3.50; CI = 1.50-8.17). Although significant on univariate analysis, advanced underlying disease before BMT and the development of active CMV disease after BMT were not independent risk factors. In conclusion, the development of CMV antigenemia after BMT was associated with increased 1-year mortality, while the development of active CMV di...Continue Reading

Citations

Jun 26, 2012·Indian Pediatrics·Shailesh KanvindeSampada Patwardhan
Aug 31, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ellen MeijerLeo F Verdonck
Oct 15, 2003·Clinical Microbiology Reviews·Ellen MeijerLeo F Verdonck
Jul 26, 2015·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Susanna K TanBenjamin A Pinsky
Apr 20, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·R Grant RoweLeslie Lehmann
Jan 10, 2002·Bone Marrow Transplantation·C M MachadoC S Pannuti
May 22, 2007·Transplant Infectious Disease : an Official Journal of the Transplantation Society·V BordonC Dhooge
Jun 28, 2019·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Estela GiménezDavid Navarro
Oct 13, 2006·Current Opinion in Infectious Diseases·J Klastersky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.